2022
DOI: 10.1016/j.crmeth.2021.100139
|View full text |Cite
|
Sign up to set email alerts
|

Toward hypothesis-driven, personalized microbiome screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…It will particularly be beneficial in understanding the disease‐triggering microbial strains helping to discover tailored‐treatment approaches. The genomic screening will help to account for the significant degree of interpersonal variations and will become increasingly relevant to precisely study the genotype and phenotype of an individual 44 . Taken together, they will enhance the quality of oral microbiome studies to identify the diagnostic and treatment markers.…”
Section: Discussionmentioning
confidence: 99%
“…It will particularly be beneficial in understanding the disease‐triggering microbial strains helping to discover tailored‐treatment approaches. The genomic screening will help to account for the significant degree of interpersonal variations and will become increasingly relevant to precisely study the genotype and phenotype of an individual 44 . Taken together, they will enhance the quality of oral microbiome studies to identify the diagnostic and treatment markers.…”
Section: Discussionmentioning
confidence: 99%
“…Going forward, it would be important to not only have iPSC-derived ENs, but also iPSC-derived epithelial cells inside the device, to transition the device into a personalized model. Importantly, this personalized model could be used to test pre-, pro-, and synbiotics 10 , 11 and potentially develop personalized screening and therapeutic approaches 17 . Personalized neuroHuMiX could eventually shed light on the 'dark matter' of the human gut microbiome and its interactions with the nervous system along the gut microbiome-nervous system axis, paving the way for therapeutic assessment and interventions.…”
Section: Discussionmentioning
confidence: 99%
“…A limitation of these metagenomic approaches compared to culture-based method is the potential loss of information on low-abundance strains as well as low strain-resolution accuracy, problems that can be addressed by combining metagenome-assembled regions with newly discovered single-cell metagenomic methods. However, these methods remain prohibitive in terms of costs and analysis challenges ( 310 , 311 ). New microfluidic methods based on droplets containing microbial cells from fecal samples are also under evaluation to produce complete and precise microbial characterization that would enable an improved definition of overall microbial function ( 311 , 312 ).…”
Section: Personal Genomicsmentioning
confidence: 99%
“…However, these methods remain prohibitive in terms of costs and analysis challenges ( 310 , 311 ). New microfluidic methods based on droplets containing microbial cells from fecal samples are also under evaluation to produce complete and precise microbial characterization that would enable an improved definition of overall microbial function ( 311 , 312 ).…”
Section: Personal Genomicsmentioning
confidence: 99%